Explore your weight-loss treatment options. Check eligibility

Tirzepatide
Weight Loss Online

Explore clinician-guided treatment from home.

Tirzepatide plans

Medication starting at

$116

Four-week starter supply. Additional fees apply. See full pricing details.

  • Licensed
    U.S. clinicians
  • Home
    delivery
  • No insurance
    required
Check My Eligibility

Prescription treatment only when medically appropriate. Individual results vary.

Illustration of a woman relaxing at home with her smartphone
Consult with U.S. licensed clinicians online
Prescriptions delivered to your home
Medical review before treatment
AI-generated illustration. Individual results vary.
Understand your treatment

Tirzepatide pricing and care

Compare advertised medication prices for four weekly doses. Your clinician determines the appropriate dose; these are not packages to select without medical guidance.

Before you pay

  • Medication starts at $116 for the 2.5 mg starter tier.
  • Checkout adds $35 shipping and a separate consultation fee. Confirm any laboratory and follow-up charges.
  • Higher-dose prices differ. Confirm the total for each refill, renewal arrangements, and cancellation terms before payment.
  • Confirm the exact product, formulation, and dispensing pharmacy. These prices are not a quote for branded Zepbound.

Refund policy · Terms · Ask about your plan

$116Four-week supply
2.5mg

4 weekly doses

Shipping and consultation extra

$128Four-week supply
5mg

4 weekly doses

Shipping and consultation extra

$139Four-week supply
7.5mg

4 weekly doses

Shipping and consultation extra

$151Four-week supply
10mg

4 weekly doses

Shipping and consultation extra

$162Four-week supply
12.5mg

4 weekly doses

Shipping and consultation extra

$168Four-week supply
15mg

4 weekly doses

Shipping and consultation extra

Medication prices for four weekly doses; additional fees apply.
Dose per weekFour-week price
2.5mg$116
5mg$128
7.5mg$139
10mg$151
12.5mg$162
15mg$168

Know which product you are prescribed

Zepbound contains tirzepatide. Brand-name and compounded medicines are not interchangeable descriptions. Ask your clinician and pharmacy to identify your prescribed product.

Compounded medicines are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness, or quality. They should only be used when a patient's needs cannot be met by an FDA-approved drug. Read the FDA's guidance.

Set expectations with your clinician

Zepbound is used with dietary changes and physical activity for weight management. Results vary, and follow-up helps assess benefits, tolerance, and continued suitability. Prescribing information.

Do not change your dose based on a pricing tier. Explore results and expectations, or see the care process.

Before you start

Eligibility and important safety information

A clinician assesses your medical history and whether treatment is appropriate. An assessment does not guarantee a prescription.

Who may qualify?

Adults with obesity, or overweight with a weight-related condition, may be considered for Zepbound alongside dietary changes and physical activity. Explore eligibility.

What should you disclose?

Do not use Zepbound with a personal or family history of medullary thyroid cancer, MEN 2, or a serious allergy to its ingredients. Discuss pregnancy, other medicines, and planned procedures with your clinician.

Side effects and follow-up

Nausea, vomiting, diarrhea, and constipation can occur. Seek prompt medical attention for severe persistent abdominal pain or allergic symptoms. Review side effects and dose changes with your clinician. Read the safety guide.

This is a brief overview, not the complete safety information. Read the manufacturer's prescribing information. Brand information does not identify the product supplied through a Doko plan.

Editorial update: . Sources are linked for reference; this date is not a clinician-review certification.

How it works

Your next step, made clearer.

From your first questions to ongoing check-ins, here is what online care can involve.

  1. 01

    Share your story

    Start with your goals, medical history, current medications, and previous weight loss treatment.

  2. 02

    Get a medical review

    A clinician reviews your information and determines whether tirzepatide may be appropriate for you.

  3. 03

    Understand your plan

    If prescribed, discuss dosing, potential side effects, costs, and pharmacy arrangements before starting.

  4. 04

    Keep checking in

    Follow up on progress and tolerance, and review any treatment changes with your clinician.

Completing an assessment does not guarantee a prescription. Your clinician helps determine the next step.

Start my assessment
Our medical team

Real people. Thoughtful care.

Meet clinicians from the Doko medical team, supporting patients across weight management and virtual healthcare.

Dr. Andrew Morel, MD

Dr. Andrew Morel, MD

Lead Diabetes Care

Dr. Edmond Samadi, MD

Dr. Edmond Samadi, MD

Primary Care Support

Nigel James, PA-C, PA

Nigel James, PA-C, PA

Metabolic Health

Dr. Fremlin Dekyi, MD

Dr. Fremlin Dekyi, MD

Preventive Care

Dr. Yasmen Atef Srour, MD

Dr. Yasmen Atef Srour, MD

Urgent Visit Care

Your treating clinician is assigned based on availability and care needs.

Tirzepatide is a medication option used in medically supervised weight-management care for eligible adults.

Online review can help patients understand whether Tirzepatide may fit their goals, medical history, and safety needs before treatment is considered.

How online Tirzepatide care usually works

A clinician reviews eligibility, current medications, weight-related health conditions, prior treatment history, and risk factors before deciding whether Tirzepatide is appropriate.

If approved, the plan may include dose guidance, shipment coordination, refill expectations, and follow-up to monitor progress and tolerance.

What makes Tirzepatide different

Tirzepatide acts on GLP-1 and GIP pathways, which may support appetite regulation and metabolic response for some patients.

Clinical results can be strong, but the right medication still depends on medical review, side-effect tolerance, availability, and cost.

Why medical review matters

Tirzepatide is not a one-size-fits-all treatment. A provider should review health history, contraindications, and practical follow-up needs before treatment starts.

This is especially important for patients with digestive concerns, gallbladder history, pancreatitis risk, diabetes medications, or complex medication lists.

What patients usually want to confirm

  • Whether they qualify for Tirzepatide treatment.
  • How weekly dosing and dose increases are managed.
  • What side effects are common and when symptoms need attention.
  • How follow-up, shipping, and refill planning work.
Best next step

Use consultation to turn search intent into a real treatment decision

Patients usually get more value from medical review, fit assessment, and follow-up planning than from choosing a medication based only on headlines or social posts.

Frequently asked questions

Yes. A telehealth consultation can help determine whether Tirzepatide is appropriate based on eligibility, health history, and safety considerations.

Tirzepatide for weight management is generally used as a once-weekly injection, with dosing and progression determined by the treating clinician.

The advertised starter price is for a four-week medication supply. Checkout adds shipping and a separate consultation fee. Confirm any lab charges, the exact product, and the full total before paying.

No. Your clinician determines the dose and any changes based on your treatment history and tolerance. A higher price tier is not a recommendation to increase your dose.

Confirm the refill price, renewal arrangements, and cancellation terms with support before payment. Consult the Doko refund policy for medication refund and exchange conditions.

Yes. Follow-up helps monitor tolerance, progress, dose planning, and side effects.

Persistent vomiting, dehydration, severe abdominal symptoms, chest pain, or other urgent concerns should be evaluated in person.